ZBIO Latest Headlines

Buy Rating Reaffirmed on Optimized SunStone Phase 2b Setup and Biomarker Upside, Price Target Unchanged at $48

at www.tipranks.com (Wed, 28-Oct 6:45 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (HCA), Zenas BioPharma, Inc. (ZBIO) and Incyte (INCY)

at www.tipranks.com (Tue, 27-Oct 9:50 PM)

Zenas BioPharma highlights new-hire equity incentives with 74,900 RSUs tied to four-year retention

Market Chameleon (Mon, 19-Oct 11:37 AM)

Zenas BioPharma spotlights hiring momentum with 152,600-share inducement equity grants

Market Chameleon (Mon, 21-Sep 11:35 AM)